喜悦智行 reported revenue of ¥0.22B for the period ended 2026-06-30, +4.5% year on year. Net income was ¥-0.01B, a -2.4% net margin on a 16.0% gross margin. The largest revenue line is 可循环包装产品 at 50% of the total. Free cash flow for the period was ¥0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | +4.5% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 16.0% | Net margin -2.4% |
| Revenue Q/Q | +18.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 可循环包装产品 | ¥0.11B | 50.4% |
| 租赁及运营服务 | ¥0.10B | 45.0% |
| 其他 | ¥0.01B | 4.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 84.0% |
| R&D | ¥0.01B | 2.4% |
| SG&A | ¥0.03B | 13.0% |
| Tax & other | ¥0.00B | 1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥1.11B |
| Total liabilities | ¥0.21B |
| Shareholders' equity | ¥0.90B |
| Equity / assets | 81.2% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.03B |
| Cash conversion (OCF / net income) | -1247% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
迈赫股份 ・ 大族数控 ・ 诚达药业 ・ 朗威股份 ・ 国泰环保 ・ 联特科技 ・ 三元生物 ・ 华兰疫苗 ・ 中亦科技 ・ 联合化学 ・ 金杨精密 ・ 亨迪药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies